The result of the phase 2 trial for patients with Alcohol Use Disorder (AUD) study has been published in The Lancet Regional Health – Europe. The result shows that two existing medications with [...]
The phase II Proof of Concept (COMB study protocol has been published at PLOS ONE, an inclusive journal community for research in science and medicine. This is an important step in the [...]
At the 36th ECNP Congress in Barcelona Spain October 6-10, 2023, Professor Bo Söderpalm, Addiction Biology Unit, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden, [...]
Sobrera Pharma AB, a Swedish pharmaceutical company developing therapies for treatment and prevention of Alcohol Use Disorder (AUD), today announced successful results from a Phase 2 trial [...]
